English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
DNA damage, oncogene activation and chromatin
Share :
ECCO 15 - ESMO 34
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
29 Sep 2009
Views:
14263
Rating:
Save
Rate video
Dr Fabrizio d'Adda di Fagagna - Principal Investigator, IFOM-IEO, Milan, Italy
Dr Fabrizio d'Adda di Fagagna, Principal Investigator, IFOM-IEO, Milan, Italy
Categories:
Biology
Cytotoxics
Related Videos
ESMO and WCLC: Latest developments in EGFR mutated NSCLC
Dr Matthew Krebs, Dr Antonio Passaro, Dr Enriqueta Felip and Prof Pascale...
18 Oct 2024
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
Dr Marina Garassino - University of Chicago, Chicago, USA
26 Sep 2024
ESMO 2024: Latest in EGFR mutated NSCLC
Prof Ignacio Gil-Bazo, Dr Mariana Brandão, Prof Benjamin Besse and Prof...
16 Sep 2024
ESMO 2024: Latest updates in mRCC
Dr Javier Puente, Dr Guillermo De Velasco, Dr Cristina Suárez and Prof Stéphane...
15 Sep 2024
Understanding the use of PARPi combinations to treat patients with mCRPC
Prof Axel Merseburger, Dr Friederike Schlurmann, Dr Elena Castro and Prof...
15 Sep 2024
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof...
15 Sep 2024
Trastuzumab deruxtecan effective against brain metastases in HER2-positive...
Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA
14 Sep 2024
Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival...
Dr Oleg Gluz - Evangeliches Krankenhaus Bethesda Klinik, Mönchengladbach...
14 Sep 2024
Multiple myeloma In Rwanda: The need for further research
Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda
6 Aug 2024
More from
e
cancer